Insights on the role of diabetes and geographic variation in patients with criticial limb ischaemia

European Journal of Vascular and Endovascular Surgery

Volumn 42, Issue 3, 2011, Pages 365-373

  Van Belle, E ^a   Nikol, S ^b   Norgren, L ^c   Baumgartner, I ^d   Driver, V ^e   Hiatt, W R ^f   Belch, J ^g  

^a UNIV LILLE   (France)

^b DEPARTMENT OF CARDIOLOGY   (Germany)

^c ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^d BERN UNIVERSITY HOSPITAL   (Switzerland)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Critical limb ischaemia; Diabetes; Gene therapy; Risk factors

Indexed keywords

ANALGESIC AGENT; ANTICOAGULANT AGENT; ANTIDIABETIC AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; OPIATE; PLACEBO; RIFERMINOGENE PECAPLASMID;

AGED; AMPUTATION; ARTICLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DIABETES MELLITUS; DIABETIC PATIENT; DISEASE ASSOCIATION; DOUBLE BLIND PROCEDURE; DRUG SAFETY; FEMALE; FOLLOW UP; HEALTH STATUS; HEMODYNAMIC MONITORING; HUMAN; HYPERCHOLESTEROLEMIA; HYPERLIPIDEMIA; HYPERTENSION; KIDNEY FAILURE; LEG; LEG REVASCULARIZATION; LIMB ISCHEMIA; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN DEFECT; SMOKING; VASCULAR LESION;

AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; ARTERIAL OCCLUSIVE DISEASES; DIABETIC ANGIOPATHIES; FEMALE; FIBROBLAST GROWTH FACTOR 1; HUMANS; INTERNATIONALITY; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; RESEARCH DESIGN;

EID: 80051663562     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2011.04.030     Document Type: Article

References (17)

1. S. Novo, G. Coppola, and G. Milio Critical limb ischemia: definition and natural history Curr Drug Targets Cardiovasc Haematol Disord 4 2004 219 225 (Pubitemid 39162412)
2. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-Society Consensus for the management of peripheral arterial disease (TASC II) J Vasc Surg 45 Suppl. S 2007 S5 S67
3. V. Bertele, M.C. Roncaglioni, J. Pangrazzi, E. Terzian, and E.G. Tognoni Clinical outcome and its predictors in 1560 patients with critical leg ischaemia. Chronic Critical Leg Ischaemia Group Eur J Vasc Endovasc Surg 18 1999 401 410
4. Ruffolo AJ, Romano M, Ciapponi A. Prostanoids for critical limb ischaemia. Cochrane Database Syst Rev:CD006544.
5. R. Gupta, J. Tongers, and D.W. Losordo Human studies of angiogenic gene therapy Circ Res 105 2009 724 736
6. F. Soubrier, B. Cameron, B. Manse, S. Somarriba, C. Dubertret, and G. Jaslin pCOR: a new design of plasmid vectors for nonviral gene therapy Gene Ther 6 1999 1482 1488 (Pubitemid 29396737)
7. I. Baumgartner, N. Chronos, A. Comerota, T. Henry, J.P. Pasquet, and F. Finiels Local gene transfer and expression following intramuscular administration of FGF-1 plasmid DNA in patients with critical limb ischemia Mol Ther 17 2009 914 921
8. B. Witzenbichler, A. Mahfoudi, F. Soubrier, A. Le Roux, D. Branellec, and H.P. Schultheiss Intramuscular gene transfer of fibroblast growth factor-1 using improved pCOR plasmid design stimulates collateral formation in a rabbit ischemic hindlimb model J Mol Med 84 2006 491 502 (Pubitemid 43801328)
9. A. Caron, S. Michelet, S. Sordello, M.A. Ivanov, P. Delaere, and D. Branellec Human FGF-1 gene transfer promotes the formation of collateral vessels and arterioles in ischemic muscles of hypercholesterolemic hamsters J Gene Med 6 2004 1033 1045 (Pubitemid 40232986)
10. S. Nikol, I. Baumgartner, E. Van Belle, C. Diehm, A. Visona, and M.C. Capogrossi Therapeutic angiogenesis with intramuscular NV1FGF improves amputation-free survival in patients with critical limb ischemia Mol Ther 16 2008 972 978 (Pubitemid 351587109)
11. S. Rajagopalan, E.R. Mohler 3rd, R.J. Lederman, F.O. Mendelsohn, J.F. Saucedo, and C.K. Goldman Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication Circulation 108 2003 1933 1938 (Pubitemid 37296537)
12. R.J. Powell, M. Simons, F.O. Mendelsohn, G. Daniel, T.D. Henry, and M. Koga Results of a double-blind, placebo-controlled study to assess the safety of intramuscular injection of hepatocyte growth factor plasmid to improve limb perfusion in patients with critical limb ischemia Circulation 118 2008 58 65
13. Krempf M, Parhofer KG, Steg PG, Bhatt DL, Ohman EM, Rother J, et al. Cardiovascular event rates in diabetic and nondiabetic individuals with and without established atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry). Am J Cardiol;105:667-71.
14. P.P. Cacoub, M.T. Abola, I. Baumgartner, D.L. Bhatt, M.A. Creager, and C.S. Liau Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry Atherosclerosis 204 2009 e86 e92
15. M. Deneuville, and A. Perrouillet Survival and quality of life after arterial revascularization or major amputation for critical leg ischemia in Guadeloupe Ann Vasc Surg 20 2006 753 760 (Pubitemid 46020502)
16. EuroQol-a new facility for the measurement of health-related quality of life. The EuroQol Group Health Policy 16 1990 199 208
17. S. Lange, C. Diehm, H. Darius, R. Haberl, J.R. Allenberg, and D. Pittrow High prevalence of peripheral arterial disease and low treatment rates in elderly primary care patients with diabetes Exp Clin Endocrinol Diabetes 112 2004 566 573 (Pubitemid 39664695)